SMAD2 and idiopathic pulmonary fibrosis: Transcription of lncITPF isunder the control of TGF-β1/Smad2/3 (Song et al., 2019).For IPF treatment, the DR8 peptide (DHNNPQIR-NH2),which has a powerful antioxidant activity, was proposed.In an animal experiment with bleomycin-induced IPF, it wasshown that after the use of DR8, fibrosis indicators, includingprofibrogenic and pro-inflammatory cytokines and markerproteins, were significantly reduced.